First-year discontinuation commonly reflects high out-of-pocket costs coupled with expectations that weight loss will be ...
In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results